VCEL Q1 2019 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$22M+21.0% YoY

Gross Profit

$13M60.4% margin

Operating Income

-$3M-15.4% margin

Net Income

-$3M-13.0% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

-30.4%

Cash Flow

Operating Cash Flow

$154,000

Free Cash Flow

-$78,000

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$141M

Total Liabilities

$38M

Stockholders' Equity

$103M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$18M	+21.0%
Gross Profit	$13M	$10M	+27.1%
Operating Income	-$3M	-$4M	+22.3%
Net Income	-$3M	-$8M	+62.9%

Revenue Segments

Product

$22M100%